Daniel is a member of the Patents Technology & Life Sciences Practice Area. His practice focuses on advising and representing national and international pharmaceutical companies and medical device manufacturers, with a particular emphasis on drug advertising law and regulatory issues in the field of pharmaceutical and medical device law.
Adoption of Commission Implementing Regulation (EU) 2025/2086: New Rules on the Joint Clinical Assessment of Medical Devices and In Vitro Diagnostic Medical Devices
par Irina Rebin et Daniel Dietrich
Reform of the Veterinary Medicines Act
par plusieurs auteurs
par plusieurs auteurs
par plusieurs auteurs
par plusieurs auteurs
par plusieurs auteurs
par plusieurs auteurs